Press Releases Shield Therapeutics plc

Equities

Delayed London S.E. Other stock markets 07:29:41 15/05/2024 pm IST			5-day change	1st Jan Change
1.84 ^GBX	-8.00%		+18.71%	-72.54%

10/05	Shield Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2023	CI
30/04	EARNINGS AND TRADING: Software Circle & Beximco report higher revenue	AN

Shield Therapeutics : 2023 Annual Report and Accounts	11/05	PU
Shield Therapeutics : Notice of Annual General Meeting 2024	11/05	PU
Shield Therapeutics : Letter to Shareholders 2024	11/05	PU
Hardman & Co Research on Shield Therapeutics (STX): Accelerating effectiveness of enlarged sales team	15/11	EQ
Shield to Present Abstract at 26th Annual Women's Healthcare Conference 2023 on Accrufer	23/23/23	AQ
Shield Therapeutics' pricing will be "key metric" - Proactive Research Analyst	05/23/05	AQ
Shield Therapeutics "couldn't be more pleased" with Viatris collaboration	05/23/05	AQ
Shield Therapeutics : Launch Announcement	28/23/28	PU
Proactive Research Analyst says Shield Therapeutics' commercialisation drive "going well"	01/23/01	AQ
Shield Therapeutics "really starting to fire on all cylinders"	25/23/25	AQ
Shield Therapeutics : Notice of Annual General Meeting 2023	19/23/19	PU
Shield Therapeutics : 2022 Annual Report and Accounts	19/23/19	PU
Shield Therapeutics : Letter to Shareholders	19/23/19	PU
Premier Miton Group Plc - Form 8.3 - Shield Therapeutics plc	09/23/09	PR
Form 8.3 - Shield Therapeutics plc	09/23/09	AQ
Killik & Co. LLP - Form 8.3 - Shield Therapeutics Plc	09/23/09	PR
Killik & Co. LLP - Form 8.3 - Shield Therapeutics Plc	05/23/05	PR
Shield Therapeutics : Rule 2.11 Letter to Employees	04/23/04	PU
Shield Therapeutics plc - Appointment of Chief Commercial Officer	06/23/06	AQ
Proactive research analyst says Shield Therapeutics "in fast growth mode"	13/23/13	AQ

No results for this search